帕金森病模型小鼠脾懸液中輔助性T細(xì)胞17和髓系抑制性細(xì)胞數(shù)量的變化及其意義
[Abstract]:Objective to investigate the changes and significance of helper T cell 17 (Th17) and myeloid inhibitory cell (MDSC) (MDSC) in spleen suspension of (PD) mice with Parkinson's disease. Methods 40 C57BL/6 mice were randomly divided into PD group (group A), gemcitabine group (group B), gemcitabine group (group C) and control group (group D). Group B and group C received intraperitoneal injection of gemcitabine (120 mg/kg) intraperitoneally on the 7th day after 7 days of irradiation with normal saline of the same volume. The number of tyrosine hydroxylase (TH) positive cells in substantia nigra and the percentage of Th17 and MDSC cells in spleen suspension were measured after behavioral experiment on the 8th day. Results compared with those before modeling, the turning time, climbing time and suspending time of group A and B mice were significantly prolonged (P0.05). Compared with group C and group D, the time of turning head and climbing pole in group A and group B were significantly prolonged after modeling. The suspension time was significantly shortened (P0.05). The number of TH positive cells in the substantia nigra of group A was significantly lower than that in group C and group D (P0.05). The percentage of Th17,MDSC cells in splenic suspension of group A was significantly higher than that of group C and group D (P0.05). The percentage of Th17 cells in splenic suspension of group B was significantly higher than that in group A (P0.05). Pearson correlation analysis showed that there was no correlation between the percentage of Th17 and MDSC in group A and group B (r-0.319r0.04, P0.05). Conclusion the increased number of Th17,MDSC in PD model mice may be involved in the development of PD. MDSC may play an immunoregulatory role in inhibiting Th17 amplification.
【作者單位】: 江蘇大學(xué)附屬醫(yī)院神經(jīng)內(nèi)科;江蘇大學(xué)附屬醫(yī)院中心實(shí)驗(yàn)室;
【基金】:江蘇省自然科學(xué)基金(BK20160548) 江蘇省“333工程”科研項(xiàng)目(BRA2014173) 江蘇省“六大人才高峰”科研項(xiàng)目(WSN038) 鎮(zhèn)江市重點(diǎn)研發(fā)計(jì)劃(SH2016032) 鎮(zhèn)江市社會(huì)發(fā)展科技計(jì)劃項(xiàng)目(SH2015047)
【分類號(hào)】:R-332;R742.5
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李秦;趙亞群;賈雪梅;E.Bezard;趙德明;;長期維持帕金森病食蟹猴模型的探索[J];中國獸醫(yī)雜志;2006年05期
2 陳娟;李強(qiáng);;帕金森病伴發(fā)抑郁情況調(diào)查及心理干預(yù)[J];實(shí)用醫(yī)藥雜志;2010年02期
3 ;帕金森病發(fā)病機(jī)理在猴腦的實(shí)驗(yàn)研究[J];上海第二醫(yī)科大學(xué)學(xué)報(bào);1995年01期
4 王笛;于小平;王維;;制備偏側(cè)帕金森病猴模型的術(shù)前準(zhǔn)備及術(shù)后護(hù)理[J];實(shí)驗(yàn)動(dòng)物科學(xué);2014年03期
5 張瞳光,劉顯明,劉玉廣,張平,于海濤,張明堂;帕金森病的立體定向手術(shù)治療[J];青島醫(yī)學(xué)院學(xué)報(bào);1997年03期
6 鄧興力;雷德強(qiáng);劉如恩;楊智勇;馮忠堂;;帕金森病大鼠模型的建立[J];廣東醫(yī)學(xué);2012年03期
7 何靖;秦書紅;徐玉春;王萱;;帕金森病患者抑郁情緒的心理干預(yù)[J];職業(yè)與健康;2007年24期
8 劉冰;馬立;石玉龍;張伯禮;;采用單點(diǎn)雙注法制備帕金森病大鼠模型[J];立體定向和功能性神經(jīng)外科雜志;2008年05期
9 高志學(xué),劉艷生,楊莉,余化霖,許再華,蔡學(xué)敏,馬以騮,魏學(xué)忠;培養(yǎng)猴頸交感神經(jīng)節(jié)腦內(nèi)移植治療帕金森病的實(shí)驗(yàn)研究[J];中華老年醫(yī)學(xué)雜志;1998年05期
10 苑杰;王靜;王曉一;李麗娜;杜君;張郢;秦震新;徐士軍;耿宇;;帕金森病患者家屬心理狀況及社會(huì)支持度研究[J];現(xiàn)代預(yù)防醫(yī)學(xué);2010年09期
相關(guān)會(huì)議論文 前1條
1 李婧;劉巖;陳乃宏;;帕金森病大鼠模型的建立及中藥干預(yù)研究[A];中國藥理學(xué)會(huì)補(bǔ)益藥藥理專業(yè)委員會(huì)成立大會(huì)暨人參及補(bǔ)益藥學(xué)術(shù)研討會(huì)會(huì)議論文集[C];2011年
相關(guān)重要報(bào)紙文章 前6條
1 匡遠(yuǎn)深;小鼠模型助帕金森病早診早治[N];健康報(bào);2008年
2 ;日本干細(xì)胞治療帕金森病獲得突破[N];醫(yī)藥經(jīng)濟(jì)報(bào);2005年
3 匡遠(yuǎn)深;帕金森病臨床前期小鼠模型建立[N];中國醫(yī)藥報(bào);2008年
4 陳勇;美科學(xué)家研制出抗帕金森病疫苗[N];醫(yī)藥經(jīng)濟(jì)報(bào);2005年
5 陳勇;美研發(fā)帕金森病疫苗動(dòng)物實(shí)驗(yàn)效果好[N];中國醫(yī)藥報(bào);2005年
6 南方日?qǐng)?bào)記者 李R肌⊥ㄑ對(duì),
本文編號(hào):2202229
本文鏈接:http://sikaile.net/xiyixuelunwen/2202229.html